STOCK TITAN

Dycom Industries, Inc. Form 4 Filings

DY NYSE

Every Form 4 that Dycom Industries, Inc. (DY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DY filings page.

Rhea-AI Summary

Dycom Industries Inc. (DY) President & CEO Daniel S. Peyovich reported an open‑market purchase of 850 shares of Common Stock on September 9, 2026. The weighted average purchase price was $296.76 per share, with individual trades executed between $296.30 and $297.04 per share.

Following this purchase, Peyovich directly holds 61,343 shares of Dycom common stock, which includes unvested time‑vesting restricted stock units ("TRSUs"), and indirectly holds an additional 10,000 shares by trust. No Rule 10b5‑1 trading plan is reported for these transactions.

Rhea-AI Summary

DYCOM INDUSTRIES INC (DY) director David Joseph Fallon reported an open-market purchase of company stock. On 2026-09-01, he purchased 700 shares of common stock at $286.92 per share. Following this transaction, he directly holds 1,043 shares of common stock, which includes unvested Restricted Stock Units.

Rhea-AI Summary

Lenz Michael C. reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Michael C. Lenz received a grant of 343 Restricted Stock Units representing Dycom common shares on August 4, 2026. The RSUs were granted for no cash consideration and vest in a single installment on August 4, 2027. Following this grant, he holds 343 RSUs, including unvested awards.

Rhea-AI Summary

Fallon David Joseph reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc granted director David Joseph Fallon 343 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. The RSUs vest in a single installment on August 4, 2027, were granted for no consideration, and Fallon now holds 343 RSUs including unvested awards.

Rhea-AI Summary

LeClair Stephen O reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Stephen O. LeClair received a grant of 42 shares of Common Stock on August 3, 2026, recorded at $414.98 per share. After this award, he directly holds 797 shares, a total that includes unvested Restricted Stock Units (RSUs), and the transaction was not under a Rule 10b5-1 plan.

Rhea-AI Summary

Dycom Industries director Richard K. Sykes reported a grant/award acquisition of 114 shares of Common Stock on 2026-08-03 at $414.98 per share. After this award, he directly holds 21,983 shares, which include unvested Restricted Stock Units. The filing indicates this transaction was not made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

GALLAGHER PHILIP R reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc director Philip R. Gallagher received a grant of 48 shares of common stock on August 3, 2026, valued at $414.98 per share. Following this award, his direct holdings total 872 shares, including unvested restricted stock units.

Rhea-AI Summary

Skillern Raejeanne reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director stock award: Director Raejeanne Skillern received a grant of 29 shares of Dycom common stock on August 3, 2026 at a reported value of $414.98 per share. Following this award, she directly holds 489 shares, a figure that includes unvested Restricted Stock Units.

Rhea-AI Summary

Fritzsche Jennifer M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc. director Jennifer M. Fritzsche received a grant of 32 shares of common stock on August 3, 2026 at $414.98 per share. After this equity award, she directly holds 9,982 shares, including unvested RSUs. The transaction was not made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

DYCOM INDUSTRIES INC director Jennifer M. Fritzsche reported a bona fide gift of 100 shares of Common Stock. The Form 4 shows this as a gift transfer with no sale proceeds involved. After the transaction, she directly holds 9,950 shares of Dycom common stock.

Rhea-AI Summary

Fritzsche Jennifer M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Jennifer M. Fritzsche received a grant of 331 Restricted Stock Units (RSUs), each representing one share of Dycom Industries, Inc. common stock upon vesting. The RSUs vest in a single installment on the earlier of May 28, 2027 or the company’s next annual meeting of shareholders. No consideration was paid for the RSUs. Following this award, Fritzsche holds a total of 10,050 shares of common stock, including unvested RSUs.

Rhea-AI Summary

Dycom Industries director Richard K. Sykes received equity compensation in the form of restricted stock units (RSUs). The Form 4 reports two grant-type acquisitions of Dycom common stock on May 28, 2026, totaling 142 and 331 RSUs at a price of $0.00 per share.

Each RSU represents a contingent right to one share of DY common stock upon vesting. The RSUs vest in one annual installment on the earlier of May 28, 2027 or the date of the company’s next annual shareholder meeting. No cash consideration was paid for these RSUs, and Sykes’ direct holdings after one of the grants are reported at 21,869 shares, including unvested RSUs.

Rhea-AI Summary

Dycom Industries director Peter T. Pruitt Jr. reported receiving a grant of 331 shares of common stock in the form of restricted stock units (RSUs). No cash was paid for this award, which is part of his equity compensation.

Each RSU converts into one share of Dycom common stock when it vests. The RSUs vest in a single installment on the earlier of May 28, 2027 or the date of the company’s next annual shareholder meeting. After this grant, Pruitt holds 15,645 shares of common stock, including unvested RSUs.

Rhea-AI Summary

Gertel Eitan reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Eitan Gertel received an equity award in the form of restricted stock units (RSUs). The grant covers 331 RSUs, each representing a right to receive one share of Dycom Industries common stock when the units vest, with no cash paid by Gertel for the award.

The RSUs vest in a single installment on the earlier of May 28, 2027 or the date of the company’s next annual shareholder meeting. After this grant, Gertel holds 16,328 shares and RSUs of Dycom Industries common stock directly, including unvested RSUs.

Rhea-AI Summary

Skillern Raejeanne reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc. director Raejeanne Skillern received an equity award of 331 restricted stock units (RSUs). These RSUs were granted at no cost and each unit represents the right to receive one share of Dycom common stock upon vesting.

The RSUs vest in a single installment on the earlier of May 28, 2027 or the date of Dycom’s next annual shareholder meeting. After this grant, Skillern’s reported direct holdings, including unvested RSUs, total 460 shares of common stock equivalents.

Rhea-AI Summary

Sabater Carmen M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Carmen M. Sabater received an equity award of 331 shares of common stock in the form of restricted stock units (RSUs). The award was granted at no cash cost and increases her direct holdings to 6,804 shares, including unvested RSUs.

The RSUs each represent the right to receive one share of Dycom Industries common stock upon vesting. They vest in a single installment on the earlier of May 28, 2027 or the date of the company’s next annual shareholder meeting, aligning the director’s compensation with long-term shareholder interests.

Rhea-AI Summary

LeClair Stephen O reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Stephen O. LeClair received a grant of 331 restricted stock units (RSUs), each representing one share of common stock. This award increases his direct holdings to 755 shares. The RSUs vest in one installment on May 28, 2027 or at the next annual shareholder meeting, and no cash was paid for the grant.

Rhea-AI Summary

Dycom Industries director Philip R. Gallagher received an equity grant in the form of restricted stock units. The award covers 331 RSUs, each representing a contingent right to acquire one share of Dycom Industries common stock upon vesting. The RSUs vest in a single installment on the earlier of May 28, 2027 or the date of the company’s next annual shareholder meeting. No cash consideration was paid for this grant. Following this award, Gallagher’s reported direct holdings, including unvested RSUs, total 824 shares or share-equivalents.

Rhea-AI Summary

Fritzsche Jennifer M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries director Jennifer M. Fritzsche received a grant of 25 shares of common stock on May 4, 2026. The shares were valued at $429.47 per share in the filing. After this grant, she directly holds 9,719 shares of Dycom Industries common stock.

Rhea-AI Summary

Dycom Industries director Stephen O. LeClair received a grant of 28.0000 shares of Dycom Industries common stock on 2026-05-04. The shares were reported at a price of $429.4700 per share as a grant, award, or other acquisition, not an open-market purchase. Following this compensation-related transaction, his direct holdings increased to 424.0000 shares of common stock.

Rhea-AI Summary

Dycom Industries director Philip R. Gallagher received an award of 28 shares of Common Stock on May 4, 2026 at $429.47 per share. The transaction is classified as a grant, award, or other acquisition rather than an open-market purchase. Following this award, Gallagher directly holds 493 shares of Dycom Industries Common Stock.

Rhea-AI Summary

Skillern Raejeanne reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc. director Raejeanne Skillern received a grant of 41 shares of common stock on May 4, 2026 at an indicated value of $429.47 per share. Following this compensation-related award, she directly holds 129 shares of Dycom common stock.

Rhea-AI Summary

Dycom Industries VP & CAO Heather M. Floyd reported an amended insider transaction related to equity award vesting. On March 30, 2026, 627 shares of Dycom common stock were withheld at $341.96 per share to cover tax liability from vesting time-vesting and performance-vesting restricted stock units. This Form 4/A corrects an earlier report that misstated the number of shares withheld and the resulting holdings. After this tax-withholding disposition, Floyd directly holds 4,756 common shares, which include unvested time-vesting restricted stock units.

Rhea-AI Summary

Dycom Industries Executive VP & COO Kevin M. Wetherington received 3,604 shares of common stock as an equity award. The shares were acquired at no cost upon settlement of performance-vesting restricted stock units on March 30, 2026, after pre-established performance measures were met.

The performance targets were based on operating earnings and the ratio of operating cash flow to net income, each before certain items. The 3,604 shares include 1,185 supplemental shares that vested based on performance over a three-year period. Following this grant, Wetherington directly holds 20,242 shares, which include unvested time-vesting restricted stock units.

Rhea-AI Summary

Dycom Industries SVP & CFO H. Andrew DeFerrari received 9,313 shares of common stock through the settlement of performance-vesting restricted stock units on March 30, 2026, with no cash consideration. The award reflected multi-year performance measures based on operating earnings and an operating cash flow to net income ratio.

In connection with the vesting of these performance and time-based restricted stock units, 6,176 shares were withheld to cover related tax liabilities at a value of $341.96 per share. After these transactions, DeFerrari directly holds 170,971 shares of Dycom common stock, including unvested time-vesting restricted stock units.

Rhea-AI Summary

Dycom Industries VP & CAO Heather M. Floyd received 809 shares of DY common stock on March 30, 2026 through the settlement of performance-vesting restricted stock units. No cash was paid for these shares; they vested based on operating earnings and the ratio of operating cash flow to net income over a three-year period.

To cover tax liabilities from the vesting of PRSUs and time-vesting restricted stock units, 342 shares were withheld at $341.96 per share. After these transactions, she directly holds 5,041 shares of Dycom common stock, which include unvested time-vesting restricted stock units.

Rhea-AI Summary

Dycom Industries President & CEO Daniel S. Peyovich received 13,370 shares of common stock on March 30, 2026 through the settlement of performance-vesting restricted stock units (PRSUs). No cash consideration was paid for this equity award.

The PRSUs vested based on pre-established performance measures tied to operating earnings and the ratio of operating cash flow to net income, and included 4,397 supplemental shares earned over a three-year performance period. To cover tax obligations from the vesting of PRSUs and time-vesting RSUs (TRSUs), 7,862 shares were withheld at $341.96 per share.

Following these transactions, Peyovich directly holds 60,493 shares of Dycom common stock, and an additional 10,000 shares are held indirectly by a trust.

Rhea-AI Summary

Dycom Industries senior vice president, general counsel and secretary Ryan F. Urness received 6,042 shares of common stock on March 30, 2026 through the settlement of performance-vesting restricted stock units. No consideration was paid for this grant, which included 1,987 supplemental shares tied to three-year performance results.

To cover tax liabilities from the vesting of performance and time-vesting restricted stock units, 4,440 shares were withheld at a price of $341.96 per share. After these compensation-related transactions, Urness directly owns 39,978 shares of Dycom common stock, including unvested time-vesting restricted stock units.

Rhea-AI Summary

Dycom Industries senior vice president and chief human resources officer Jill L. Ramshaw received 1,177 shares of common stock on March 30, 2026 through the settlement of performance-vesting restricted stock units (PRSUs), including 387 supplemental shares tied to three-year performance measures. These awards were granted at no cash cost to her. To cover tax obligations from vesting of PRSUs and time-vesting restricted stock units (TRSUs), 637 shares were withheld at a value of $341.96 per share. After these compensation-related transactions, she directly holds 5,560 shares of Dycom common stock.

Rhea-AI Summary

Skillern Raejeanne reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Inc. director Raejeanne Skillern reported a grant of 88 restricted stock units (RSUs) of Dycom common stock. Each RSU represents a contingent right to receive one share upon vesting. The RSUs vest in a single installment on March 24, 2027, and no consideration was paid. Following this grant, Skillern holds 88 shares, which include unvested RSUs.

Rhea-AI Summary

Ramshaw Jill L reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries granted Senior Vice President and Chief Human Resources Officer Jill L. Ramshaw an award of 1,124 restricted stock units (RSUs), each representing one share of common stock, for no cash consideration.

The RSUs vest in three substantially equal annual installments beginning on March 30, 2027. After this grant, Ramshaw directly holds 5,020 shares of Dycom common stock, including unvested RSUs.

Rhea-AI Summary

Wetherington Kevin M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries Executive VP & COO Kevin M. Wetherington received a grant of 3,942 restricted stock units (RSUs), each representing one share of DY common stock upon vesting. The RSUs vest in three equal annual installments beginning on March 30, 2027, and no consideration was paid for the award. Following this grant, Wetherington holds a total of 16,638 shares and RSUs of Dycom common stock directly, including unvested RSUs. This is a compensation-related equity award rather than an open-market share purchase.

Rhea-AI Summary

DeFerrari H Andrew reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries reported that SVP & CFO H. Andrew DeFerrari received an equity grant of 2,582 restricted stock units (RSUs). No cash was paid for this award, which is a form of stock-based compensation rather than an open-market purchase.

Each RSU represents the right to receive one share of Dycom common stock as it vests. The RSUs vest in three substantially equal annual installments beginning on March 30, 2027. Following this grant, DeFerrari directly holds 167,834 shares of Dycom common stock, which includes unvested RSUs.

Rhea-AI Summary

URNESS RYAN F reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries senior vice president, general counsel and secretary Ryan F. Urness received a grant of 1,695 restricted stock units of common stock as equity compensation. No cash was paid for this award, and each unit represents a right to one share upon vesting.

The restricted stock units vest in three substantially equal annual installments beginning on March 30, 2027, aligning the award with multi-year service. After this grant, Urness directly holds 38,376 shares of Dycom common stock, which the disclosure notes includes unvested restricted stock units.

Rhea-AI Summary

Peyovich Daniel S reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries’ President & CEO Daniel S. Peyovich received 6,899 restricted stock units (RSUs) of common stock as a compensation award. Each RSU represents one share that will be delivered only after it vests, and no cash was paid for the award.

The RSUs vest in three substantially equal annual installments beginning on March 30, 2027, spreading the potential share delivery over three years. After this grant, Peyovich directly holds 54,985 shares of common stock, and an additional 10,000 shares are reported as held indirectly by a trust.

Rhea-AI Summary

Floyd Heather M reported acquisition or exercise transactions in this Form 4 filing.

Dycom Industries reported that VP & CAO Heather M. Floyd received an equity compensation grant of 1,918 restricted stock units (RSUs) of common stock. These RSUs vest in three substantially equal annual installments beginning on March 30, 2027, and no cash consideration was paid for the grant.

After this award, Floyd holds 4,574 shares and RSUs directly, including unvested RSUs. Each RSU represents a contingent right to receive one share of Dycom common stock when it vests, aligning a portion of her compensation with the company’s future performance.

Rhea-AI Summary

DYCOM INDUSTRIES INC VP & CHRO Jill L. Ramshaw reported a Form 4 transaction involving company common stock. On February 17, 2026, 114 shares were disposed of at $427.48 per share in a tax-withholding disposition related to the vesting of restricted stock units. After this withholding for tax purposes, she directly holds 3,896 shares of Dycom common stock.

Rhea-AI Summary

Dycom Industries director Philip R. Gallagher reported acquiring common stock of the company. On February 2, 2026, he acquired 32 shares of Dycom Industries common stock at a price of $383.58 per share. Following this transaction, he beneficially owned 465 shares, held in direct ownership.

Rhea-AI Summary

Industries Inc director Jennifer M. Fritzsche reported acquiring 33 shares of the company’s common stock on February 2, 2026. The shares were acquired at a price of $383.58 per share, and she now beneficially owns 9,694 common shares, held as a direct ownership position.

Rhea-AI Summary

Dycom Industries director Stephen O. LeClair acquired additional common stock in the company. On February 2, 2026, he received 59 shares of common stock at a price of $383.58 per share. Following this transaction, he directly beneficially owns 396 shares of Dycom Industries common stock.

Rhea-AI Summary

Dycom Industries director Eitan Gertel reported selling 3,645 shares of the company’s common stock. The sale took place on January 9, 2026 and is reported as an open market sale. The weighted average sale price was $345.62 per share, with the shares sold in two trades of 3,638 shares at $345.62 and 7 shares at $346.04.

After this transaction, Gertel directly holds 15,997 shares of Dycom Industries common stock. The filing reflects a single non-derivative transaction and shows that he is a director of the company, with no officer or 10% owner status indicated.

Rhea-AI Summary

Dycom Industries Inc. officer Ryan F. Urness, who serves as SVP, General Counsel & Secretary, reported a routine equity transaction on 12/02/2025. The filing shows the disposition of 318 shares of common stock at $350.06 per share, coded as an "F" transaction, which indicates shares withheld to cover taxes related to vested restricted stock units. Following this tax withholding event, Urness directly beneficially owns 36,681 shares of Dycom common stock.

Rhea-AI Summary

Dycom Industries senior vice president and chief financial officer H. Andrew DeFerrari reported a routine share withholding related to equity compensation. On 12/02/2025, 330 shares of Dycom common stock were withheld at a price of $350.06 per share to cover tax liabilities that arose when restricted stock units vested. After this transaction, DeFerrari beneficially owned 165,252 shares of Dycom common stock directly. This filing reflects an administrative tax event rather than an open-market purchase or sale.

Rhea-AI Summary

Dycom Industries Inc. reported a routine insider transaction by its President and CEO. On 11/30/2025, the executive had 1,047 shares of common stock withheld at a price of $361.53 per share to cover tax liabilities related to the vesting of restricted stock units. After this tax withholding, the officer directly beneficially owned 58,086 shares of Dycom common stock. The filing is reported on behalf of the President & CEO as a single reporting person.

Rhea-AI Summary

Dycom Industries (DY) reported that a director received 337 restricted stock units on November 7, 2025 under a Form 4 filing. Each RSU represents the right to receive one share of Dycom common stock.

The RSUs vest in a single installment on November 7, 2026, and no consideration was paid for the award. Following the transaction, the reporting person beneficially owned 337 units on a direct basis.

Rhea-AI Summary

Dycom Industries (DY) disclosed an insider transaction by a director. On 10/27/2025, the director reported an acquisition (Transaction Code A) of 52 shares of common stock at $284.16 per share. Following the transaction, the director beneficially owns 433 shares, held directly.

Rhea-AI Summary

Dycom Industries (DY) reported that a director acquired 44 shares of common stock at $284.16 per share on 10/27/2025.

Following this transaction, the director beneficially owns 9,661 shares, held directly. No derivative securities were reported.

Rhea-AI Summary

Philip R. Gallagher, a director of Dycom Industries, Inc. (DY), received 381 restricted stock units (RSUs) on 10/07/2025. Each RSU represents the right to one share of common stock and vests in one annual installment on 10/07/2026. The award was granted at $0.00 consideration, meaning no cash was paid for the RSUs. After the grant, Mr. Gallagher beneficially owns 381 shares through these RSUs, held in a direct ownership form. The Form 4 was filed jointly by one reporting person and signed under power of attorney on 10/08/2025.